Cart
sales@molnova.com
2-Aminobenzenesulfonamide
CAS No. 3306-62-5
2-Aminobenzenesulfonamide( —— )
Catalog No. M14098 CAS No. 3306-62-5
2-Aminobenzenesulfonamide is a molecule containing the sulfonamide functional group attached to an aniline.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 50MG | 36 | In Stock |
|
| 100MG | 50 | In Stock |
|
| 200MG | 77 | In Stock |
|
| 500MG | 128 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name2-Aminobenzenesulfonamide
-
NoteResearch use only, not for human use.
-
Brief Description2-Aminobenzenesulfonamide is a molecule containing the sulfonamide functional group attached to an aniline.
-
Description2-Aminobenzenesulfonamide is a molecule containing the sulfonamide functional group attached to an aniline.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorDHPS
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number3306-62-5
-
Formula Weight172.21
-
Molecular FormulaC6H8N2O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESNC1=CC=CC=C1S(N)(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.RAFFA L. Farmaco Sci. 1957;12(5):387-93.
molnova catalog
related products
-
ZPCK
ZPCK is a potent, pan autophagy inhibitor, inhibits the cargo degradation inside the vacuole and alters the process of autophagy in mammalian cells.
-
2,2-Dihydroxy chalco...
2,2'-Dihydroxy chalcone is a potent inhibitor of β-glucuronidase (IC50=1.6±0.2 μM) and lysozyme (IC50=1.4±0.2 μM) release from rat neutrophils stimulated with fMLP/CB.2,2'-Dihydroxy chalcone has inhibitory activity against Escherichia coli, Shigella fowleri, Staphylococcus albicans and Staphylococcus aureus.
-
Nilotinib hydrochlor...
Nilotinib hydrochloride(AMN-107 HCl) is an orally available Bcr-Abl tyrosine kinase inhibitor with antitumor activity for modulation of neuroinflammation and cognitive deficits, and may be used in studies of chronic myelogenous leukemia.
